Efficacy and safety of Depemokimab in asthma with eosinophilic phenotype: a systematic review and meta-analysis of randomized controlled trials. [PDF]
BMC ImmunolGill BA +9 more
europepmc +1 more source
PDE4-Selective Inhibition in Chronic Obstructive Pulmonary Disease and Pulmonary Fibrosis: Different Agents or Different Targets? [PDF]
Life (Basel)Bolger GB.
europepmc +1 more source
[Bronchodilating agents. Prevention and therapy].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1974 openaire +1 more source
Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits. [PDF]
LungCazzola M +4 more
europepmc +1 more source
Treatment Decisions for Stable Chronic Obstructive Pulmonary Disease in China: An Observational Cross-Sectional Survey Based on Multivariate Discrete Choice Modeling. [PDF]
Int J Chron Obstruct Pulmon DisCui J, Tang C, Li H, Zhou Y, Li S.
europepmc +1 more source
Monitoring COPD patients systemic and bronchial eosinophilic inflammation in a 2-year follow-up: few concerns. [PDF]
BMC Pulm MedBalan D, Manu MK.
europepmc +1 more source
Patient response and remission in respiratory disease: Special focus on severe asthma and chronic obstructive pulmonary disease. [PDF]
J Int Med ResColantuono S +6 more
europepmc +1 more source
Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate. [PDF]
Clin PharmacokinetHassan MI +4 more
europepmc +1 more source
The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study. [PDF]
BMC Pulm MedErbay M +3 more
europepmc +1 more source
Assessment of ventilation heterogeneity in severe asthma using phase-resolved functional lung magnetic resonance imaging. [PDF]
Physiol RepFoo CT +5 more
europepmc +1 more source